Isothiocyanates (Moringin / 4-O-α-L-rhamnosyloxy-benzyl isothiocyanate)

Moderate

Mechanism of Action

Generated from glucosinolate precursors via myrosinase during tissue disruption; potently inhibits NF-κB signalling and downstream pro-inflammatory cytokine production (IL-6, TNF-α, IL-1β); induces Nrf2-mediated antioxidant response element (ARE) activation, upregulating Phase II detoxification enzymes (glutathione S-transferase, NAD(P)H quinone oxidoreductase); demonstrates direct antimicrobial activity by reacting with sulfhydryl groups in bacterial cysteine proteases.

Research Notes

MoringaAfrican

In vitro and rodent studies confirm robust anti-inflammatory, cytoprotective, and antimicrobial activity. A 2021 randomised controlled trial (n=120) in type 2 diabetic patients found that 4 g/day of Moringa leaf powder over 12 weeks significantly reduced fasting blood glucose (−18%) and HbA1c (−0.7%). Antioxidant and hepatoprotective effects are consistently demonstrated in preclinical models; human clinical data are emerging.

Found In 1 Herb

Moringa

African

3D Molecular Structure

Glucosinolate hydrolysis product

Drag to rotate · Click atoms to explore

Isothiocyanates (Moringin / 4-O-α-L-rhamnosyloxy-benzyl isothiocyanate)

Glucosinolate hydrolysis productBioactive phytochemical with therapeutic properties

Representative pattern: C₄H₂NO

Atoms

Carbon

Oxygen

Nitrogen

Hydrogen

Live Research

Open on PubMed

This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare practitioner before using any herbal product.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This content is for educational purposes only and is not a substitute for professional medical advice.